Endovascular Treatment of a Dural Arteriovenous Fistula after Cerebral Sinovenous Thrombosis in a Child

Gatto, Luana Antunes Maranha; Souza, Thiago Ferreira Simões De; Alves, G; Miranda, Tayná; Koppe, Gelson Luis; Demartini, Zeferino

doi:10.1159/000494563

Cited by 6 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 11 case reports and 4 retrospective cohort studies were included from our review of the literature. [3][4][5][9][10][11][12][13][14][15][16][17][18][19][20] Most studies involved patients who presented with dAVFs in concurrence with diagnoses of CVST. Most of the dAVFs diagnosed after the CVST diagnosis were identified when patients experienced symptoms such as headaches, tinnitus, dizziness, and blurred vision.…”

Section: Resultsmentioning

confidence: 99%

Dural arteriovenous fistula in the setting of cerebral venous sinus thrombosis and COVID-19 infection

Liang,

Bounajem,

Shoskes

et al. 2024

Neurosurgical Focus

View full text Add to dashboard Cite

OBJECTIVE The aim of this study was to examine the presence of concurrent venous thrombosis and COVID-19 infections in patients with dural arteriovenous fistulas (dAVFs). METHODS An analysis of all patients diagnosed with dAVF via cerebral angiography by the senior author was conducted, with special attention given to the presence of cerebral venous sinus thrombosis (CVST) and COVID-19 infection. General demographics, clinical presentation, presence of CVST, and COVID-19 infection status were reported. RESULTS A total of 30 patients with dAVFs were included in this study. Three patients were diagnosed with COVID-19 (10%), with one of these patients developing CVST (33%) at 6 months postinfection. Of the 27 patients not infected with COVID-19, one was diagnosed with a likely chronic CVST at the time of presentation of dAVF (4%). A total of 11 case reports and 3 retrospective studies describing patients diagnosed with CVST at or after diagnosis of dAVFs have been reported in the literature. The incidence of dAVFs in patients with CVST has been reported as 2.4%, and the incidence of dAVF has reportedly increased five- to tenfold since the COVID-19 pandemic. CONCLUSIONS COVID-19 infections may pose as an emerging risk factor for the development of CVST and subsequent dAVF development. To the authors’ knowledge, this study presents the first cases in the literature describing a temporal relationship between COVID-19 and development of a dAVF with CVST. The effect of both COVID-19 and associated vaccines should be further assessed in future studies to examine its impact as an effect modifier on the association of dAVF and CVST.

show abstract

Section: Resultsmentioning

confidence: 99%

Dural arteriovenous fistula in the setting of cerebral venous sinus thrombosis and COVID-19 infection

Liang,

Bounajem,

Shoskes

et al. 2024

Neurosurgical Focus

View full text Add to dashboard Cite

show abstract

Characteristics and outcomes of pediatric dural arteriovenous fistulas: a systematic review

Maleknia,

Hale,

Savage

et al. 2023

Childs Nerv Syst

View full text Add to dashboard Cite

BackgroundDural arteriovenous stulas (dAVF) are arteriovenous shunts in communication with the dural vasculature in the brain or spine. Apart from single-center series, risk factors and treatment outcomes for pediatric dAVFs are largely undescribed. MethodsWe performed a systematic literature review of pediatric (< 18 years at diagnosis) intracranial and spinal dAVF according to PRISMA guidelines. We queried PubMed, CINAHL, SCOPUS, and Embase databases without time/date restriction. Search strings included a variety of MeSH keywords relating to dural AV stulas in combination with MeSH keywords related to pediatric cases (see Appendix). Manuscripts describing patients diagnosed with dural sinus malformations or pial AVF were excluded. ResultsWe identi ed 61 studies describing 69 individual patients. Overall, dAVF were more common in males (55.1%) with a mean age of diagnosis (5.17 ± 4.42 years). Approximately 20.2% of patients presented with cardiovascular disease (CVD), and 31.9% were discovered incidentally on neuroimaging studies.Transverse-sigmoid junction was the most common location (17.3%). Ninety-three percent (64 patients) were treated, most commonly using endovascular embolization (68.1%) followed by surgery (8.7%) and radiosurgery (2.9%). Almost half (43.8%) of dAVFs were completely obliterated. Of the 64 procedures, there were 19 neurological complications (29.7%) of varying severity where 12.5% were considered transient (i.e., pseudomeningocele) and 17.2% permanent (i.e., mortality secondary to acute sinus thrombosis, etc.). ConclusionThere is a paucity of information on pediatric dAVFs. This systematic review summarizes the published cases of dAVFs in the pediatric population. While the rate of missing data is high, there is publication bias, and precise details regarding complications are di cult to ascertain, this review serves as a descriptive summary of pediatric dAVFs.

show abstract

Dural Arteriovenous Fistula Complicated with Cerebral Venous Sinus Thrombosis

et al. 2020

View full text Add to dashboard Cite

Endovascular Treatment of a Dural Arteriovenous Fistula after Cerebral Sinovenous Thrombosis in a Child

Cited by 6 publications

References 10 publications

Dural arteriovenous fistula in the setting of cerebral venous sinus thrombosis and COVID-19 infection

Dural arteriovenous fistula in the setting of cerebral venous sinus thrombosis and COVID-19 infection

Characteristics and outcomes of pediatric dural arteriovenous fistulas: a systematic review

Dural Arteriovenous Fistula Complicated with Cerebral Venous Sinus Thrombosis

Contact Info

Product

Resources

About